Seven-Month Analysis of Five SARS-CoV-2 Antibody Assay Results after ChAdOx1 nCoV-19 Vaccination: Significant Decrease in SARS-CoV-2 Antibody Titer

We investigated the longevity rates of antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) after a complete ChAdOx1 nCoV-19 vaccination, which are rare and important to estimate their efficacy and establish a vaccination strategy. We assessed the positivity rates and changes o...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeong, Seri, Lee, Nuri, Lee, Su-Kyung, Cho, Eun-Jung, Hyun, Jungwon, Park, Min-Jeong, Song, Wonkeun, Jung, Eun-Ju, Woo, Heungjeong, Seo, Yu-Bin, Park, Jin-Ju, Kim, Hyun-Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8774861/
https://www.ncbi.nlm.nih.gov/pubmed/35054251
http://dx.doi.org/10.3390/diagnostics12010085

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8774861/
https://www.ncbi.nlm.nih.gov/pubmed/35054251
http://dx.doi.org/10.3390/diagnostics12010085

Ejemplares similares